HIV vaccine makers ready for human testing
There's some good news for a change.
An experimental HIV vaccine developed by an Ontario researcher may soon be approved for human testing in the United States.
The vaccine was developed by University of Western Ontario professor Dr. Chil-Yong Kang, who is being supported by Sumagen Canada Inc.
The makers of the vaccine -- dubbed SAV001-H -- have sought an application from the U.S. Food and Drug Administration to begin human testing.
There's some good news for a change.